mRNA Synthesis Raw Materials Market Forecast and Growth Opportunities Ahead
The global mRNA synthesis raw materials market size is projected to reach USD 1.99 billion by 2030 , according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.85% from 2024 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period. Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets ...